Literature DB >> 6168279

Interaction between homozygous beta (0) thalassaemia and the Swiss type of hereditary persistence of fetal haemoglobin.

M D Cappellini, G Fiorelli, L F Bernini.   

Abstract

The interaction between beta(0) thalassemia and an heterocellular form of hereditary persistence of fetal haemoglobin (HPFH), presumably of the Swiss type, has been studied in three generations of a family in which both traits occur. The haematological parameters and the segregation of the two characters in the family suggest that the propositus, a 52-year-old male from southern Sardinia, is homozygous for beta(0) thalassemia and carrier of the HPFH. In spite of the complete suppression of adult haemoglobin synthesis, the patient is not anaemic and shows only morphological abnormalities of the red cells associated with a moderate decrease of the erythrocyte life span. Studies of the synthesis of haemoglobin chains in vitro have revealed only a mild degree of unbalance in the propositus, with a gamma/alpha ratio of 0.67, and a very slight unbalance in a 3-year-old child heterozygous for beta thalassaemia and HPFH. Preliminary analysis of the linkage between this kind of heterocellular HPFH and the beta Hb locus has been performed, utilizing all the suitable families reported in the literature. Although positive lod scores (1.535) have been obtained at a recombination fraction of 0.20, the data available are not sufficient to conclude in favour or against the linkage between the beta Hb locus and the heterocellular type of HPFH.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6168279     DOI: 10.1111/j.1365-2141.1981.tb02753.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

Review 1.  Control of fetal hemoglobin: new insights emerging from genomics and clinical implications.

Authors:  Swee Lay Thein; Stephan Menzel; Mark Lathrop; Chad Garner
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

2.  Detection of non-deletional type of hereditary persistence of fetal hemoglobin (HPFH) condition associated with 619 bp β(°)-thalassemia deletion.

Authors:  S M Husain; M P Anandaraj
Journal:  Indian J Clin Biochem       Date:  1997-07

3.  Clinical and haematological evaluation of beta thalassaemia intermedia with increased Hb F and Hb A2 in heterozygotes: beta thalassaemia intermedia I.

Authors:  C Altay; A Gurgey
Journal:  J Med Genet       Date:  1985-06       Impact factor: 6.318

4.  Psychosocial and clinical burden of thalassaemia intermedia and its implications for prenatal diagnosis.

Authors:  S Ratip; D Skuse; J Porter; B Wonke; A Yardumian; B Modell
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

5.  Heterocellular hereditary persistence of fetal hemoglobin (HPFH). Molecular mechanisms of abnormal gamma-gene expression in association with beta thalassemia and linkage relationship with the beta-globin gene cluster.

Authors:  A Giampaolo; F Mavilio; N M Sposi; A Carè; A Massa; L Cianetti; M Petrini; R Russo; M D Cappellini; M Marinucci
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  Association of heterocellular HPFH, beta(+)-thalassaemia, and delta beta(0)-thalassaemia: haematological and molecular aspects.

Authors:  L Cianetti; A Care; N M Sposi; A Giampaolo; M Calandrini; M Petrini; A Massa; M Marinucci; F Mavilio; M Ceccanti
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

7.  Hematological status of beta-thalassemics in Madras.

Authors:  N Mohan; R Sarkar
Journal:  Indian J Pediatr       Date:  1994 May-Jun       Impact factor: 1.967

8.  Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.

Authors:  Olivier Negre; Anne-Virginie Eggimann; Yves Beuzard; Jean-Antoine Ribeil; Philippe Bourget; Suparerk Borwornpinyo; Suradej Hongeng; Salima Hacein-Bey; Marina Cavazzana; Philippe Leboulch; Emmanuel Payen
Journal:  Hum Gene Ther       Date:  2016-02       Impact factor: 5.695

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.